Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
Gilead Sciences to Acquire 49.9% Stake in Pionyr Immunotherapeutics
Gilead Sciences, Inc. (NASDAQ: GILD) reported that the company will acquire 49.9% stake in Pionyr Immunotherapeutics Inc. for USD 275 Million. The company retains an exclusive option to purchase...